Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

1.80
-0.1999-9.99%
Volume:80.53K
Turnover:151.72K
Market Cap:53.26M
PE:-1.72
High:2.00
Open:2.00
Low:1.80
Close:2.00
Loading ...
Feb 06, 2023

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Nov 22, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 21, 2022

Major Issues Report

8-K - Current report
Sep 07, 2022

Major Issues Report

8-K - Current report
Aug 22, 2022

Major Issues Report

8-K - Current report
Aug 22, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Aug 01, 2022

Major Issues Report

8-K - Current report
Aug 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 25, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 25, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 21, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 21, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 20, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 14, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 13, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 29, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 28, 2022

Correspondence

CORRESP [Cover] - Correspondence